Lapadula, G., Costarelli, S., Quiros-Roldan, E., Calabresi, A., Izzo, I., Carosi, G., et al. (2008). Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients. CLINICAL INFECTIOUS DISEASES, 46(7), 1127-1129 [10.1086/529394].

Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients

Lapadula G.
;
2008

Lettera in rivista
Adenine; Adult; Aged; Anti-HIV Agents; Atazanavir Sulfate; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Oligopeptides; Organophosphonates; Pyridines; RNA, Viral; Tenofovir; Treatment Outcome; Viral Load
English
2008
46
7
1127
1129
none
Lapadula, G., Costarelli, S., Quiros-Roldan, E., Calabresi, A., Izzo, I., Carosi, G., et al. (2008). Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients. CLINICAL INFECTIOUS DISEASES, 46(7), 1127-1129 [10.1086/529394].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/326140
Citazioni
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 30
Social impact